| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| TETRACICLINA ARENA 250 mg | TETRACYCLINUM | CAPS. | J01AA07 | W12701002 | ARENA GROUP S.A. - ROMANIA | ||||||
| TETRACICLINA ATB 250 mg | TETRACYCLINUM | CAPS. | J01AA07 | W56910001 | ANTIBIOTICE S.A. - ROMANIA | ||||||
| TETRACICLINA ATB 250 mg | TETRACYCLINUM | CAPS. | J01AA07 | W56910002 | ANTIBIOTICE S.A. - ROMANIA | ||||||
| TEYSUNO 15mg/4,35mg/11,8mg | COMBINATII (TEGAFUR+GIMERACIL+OTERACIL) | CAPS. | L01BC53 | W58736001 | NORDIC GROUP BV - OLANDA | X | |||||
| TEYSUNO 15mg/4,35mg/11,8mg | COMBINATII (TEGAFUR+GIMERACIL+OTERACIL) | CAPS. | L01BC53 | W58736002 | NORDIC GROUP BV - OLANDA | X | |||||
| TEYSUNO 20mg/5,8mg/15,8mg | COMBINATII (TEGAFUR+GIMERACIL+OTERACIL) | CAPS. | L01BC53 | W58737001 | NORDIC GROUP BV - OLANDA | X | |||||
| TEYSUNO 20mg/5,8mg/15,8mg | COMBINATII (TEGAFUR+GIMERACIL+OTERACIL) | CAPS. | L01BC53 | W58737002 | NORDIC GROUP BV - OLANDA | X | |||||
| THROMBOREDUCTIN 0,5 mg | ANAGRELIDUM | CAPS. | L01XX35 | W61708001 | AOP ORPHAN PHARMACEUTICALS AG - AUSTRIA | ||||||
| THROMBOREDUCTIN 0,5 mg | ANAGRELIDUM | CAPS. | L01XX35 | W61708002 | AOP ORPHAN PHARMACEUTICALS AG - AUSTRIA | ||||||
| TILAMCAR 16 mg/10 mg | COMBINATII (CANDESARTANUM CILEXETIL+AMLODIPINUM) | CAPS. | C09DB07 | W65646001 | SWYSSI AG - GERMANIA | ||||||
| TILAMCAR 16 mg/10 mg | COMBINATII (CANDESARTANUM CILEXETIL+AMLODIPINUM) | CAPS. | C09DB07 | W65646002 | SWYSSI AG - GERMANIA | ||||||
| TILAMCAR 16 mg/10 mg | COMBINATII (CANDESARTANUM CILEXETIL+AMLODIPINUM) | CAPS. | C09DB07 | W65646003 | SWYSSI AG - GERMANIA | ||||||
| TILAMCAR 16 mg/10 mg | COMBINATII (CANDESARTANUM CILEXETIL+AMLODIPINUM) | CAPS. | C09DB07 | W65646004 | SWYSSI AG - GERMANIA | ||||||
| TILAMCAR 16 mg/5 mg | COMBINATII (CANDESARTANUM CILEXETIL+AMLODIPINUM) | CAPS. | C09DB07 | W65645001 | SWYSSI AG - GERMANIA | ||||||
| TILAMCAR 16 mg/5 mg | COMBINATII (CANDESARTANUM CILEXETIL+AMLODIPINUM) | CAPS. | C09DB07 | W65645002 | SWYSSI AG - GERMANIA | ||||||
| TILAMCAR 16 mg/5 mg | COMBINATII (CANDESARTANUM CILEXETIL+AMLODIPINUM) | CAPS. | C09DB07 | W65645003 | SWYSSI AG - GERMANIA | ||||||
| TILAMCAR 16 mg/5 mg | COMBINATII (CANDESARTANUM CILEXETIL+AMLODIPINUM) | CAPS. | C09DB07 | W65645004 | SWYSSI AG - GERMANIA | ||||||
| TILAMCAR 8 mg/10 mg | COMBINATII (CANDESARTANUM CILEXETIL+AMLODIPINUM) | CAPS. | C09DB07 | W65644001 | SWYSSI AG - GERMANIA | ||||||
| TILAMCAR 8 mg/10 mg | COMBINATII (CANDESARTANUM CILEXETIL+AMLODIPINUM) | CAPS. | C09DB07 | W65644002 | SWYSSI AG - GERMANIA | ||||||
| TILAMCAR 8 mg/10 mg | COMBINATII (CANDESARTANUM CILEXETIL+AMLODIPINUM) | CAPS. | C09DB07 | W65644003 | SWYSSI AG - GERMANIA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman